AstraZeneca PLC (UK) Investor Sentiment

AZN Stock   10,938  94.00  0.87%   
About 52% of AstraZeneca PLC's investor base is interested to short. The analysis of overall sentiment of trading AstraZeneca PLC stock suggests that many investors are impartial at this time. The current market sentiment, together with AstraZeneca PLC's historical and current headlines, can help investors time the market. In addition, many technical investors use AstraZeneca PLC stock news signals to limit their universe of possible portfolio assets.
AstraZeneca PLC stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of AstraZeneca daily returns and investor perception about the current price of AstraZeneca PLC as well as its diversification or hedging effects on your existing portfolios.
  
over three months ago at news.google.com         
AstraZeneca Has Announced A Dividend Of UK0.776 - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
AstraZeneca stock slips despite guidance raise - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
AstraZeneca Stock Upgrading From Hold To Buy Ahead Of Q2 2024 Earnings - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Heres Why Astrazeneca is a Strong Growth Stock - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Oppenheimer Co. Inc. Buys 1,694 Shares of AstraZeneca PLC - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
We expect AstraZeneca strong revenue to continue, Morgan Stanley bullish on stock - Investing.com
Google News at Macroaxis
over six months ago at news.google.com         
First Trust Direct Indexing L.P. Purchases 798 Shares of AstraZeneca PLC - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Brookstone Capital Management Invests 315000 in AstraZeneca PLC - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Global Assets Advisory LLC Acquires Shares of 40,350 AstraZeneca PLC - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
SageView Advisory Group LLC Buys New Position in AstraZeneca PLC - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Wellington Management Group LLP Has 3.33 Billion Position in AstraZeneca PLC - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
AZN - AstraZeneca PLC Latest Stock News Market Updates - StockTitan
Google News at Macroaxis
over six months ago at news.google.com         
Brokerages Set AstraZeneca PLC Price Target at 88.00 - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Vestal Point Capital LP Invests 16.84 Million in AstraZeneca PLC - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
AstraZeneca completes acquisition of Fusion Pharmaceuticals - Seeking Alpha
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about AstraZeneca PLC that are available to investors today. That information is available publicly through AstraZeneca media outlets and privately through word of mouth or via AstraZeneca internal channels. However, regardless of the origin, that massive amount of AstraZeneca data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AstraZeneca PLC news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AstraZeneca PLC relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AstraZeneca PLC's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AstraZeneca PLC alpha.

AstraZeneca PLC Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
AstraZeneca PLC Shares Purchased by Y Intercept Hong Kong Ltd - MarketBeat
12/10/2024
2
Why Astrazeneca Outpaced the Stock Market Today - Yahoo Finance
12/20/2024

Complementary Tools for AstraZeneca Stock analysis

When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume